Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia
Clinical trial NCT04233918 · COMPLETED
Trial details
- NCT number
- NCT04233918
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-29
- Primary completion
- 2022-01-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.